Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Leukemia Research|July 20, 2020
Decitabine induction with myeloablative conditioning and allogeneic hematopoietic stem cell transplantation in high-risk patients with myeloid malignancies is associated with a high rate of infectious complicationsChristopher R D'Angelo, Aric Hall, Kaitlin M Woo, et al.
Transplantation and Cellular Therapy|December 13, 2024
Neurotoxicity and Rare Adverse Events in BCMA-Directed CAR T Cell Therapy: A Comprehensive Analysis of Real-World FAERS DataMoataz Ellithi, Magdi Elsallab, Matthew A Lunning, et al.
Leukemia & Lymphoma|December 25, 2015
Incidence and predictors of respiratory viral infections by multiplex PCR in allogeneic hematopoietic cell transplant recipients 50 years and older including geriatric assessmentChristopher R D'Angelo, Masha Kocherginsky, Jennifer Pisano, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Impact of high-fat Western diet on chronic lymphocytic leukemia disease progression and gut microbiome profile in Eμ-TCL1 miceSydney A Skupa, Jordan B Hernandez, Audrey L Smith, et al.
Leukemia & Lymphoma|August 3, 2018
Characterization of cancer comorbidity prior to allogeneic hematopoietic cell transplantationChristopher R D'Angelo, Brianna Novitsky, Sang Mee Lee, et al.
Frontiers in Oncology|August 5, 2026
Impact of high-fat Western diet on chronic lymphocytic leukemia disease progression and gut microbiome profile in Eµ-TCL1 miceSydney A Skupa, Jordan B Hernandez, Audrey L Smith, et al.
Cancer Research Communications|July 31, 2025
Gut Microbiome Profiling in Eμ-TCL1 Mice Reveals Intestinal Changes and a Dysbiotic Signature Specific to Chronic Lymphocytic LeukemiaSydney A Skupa, Kathryn M Cooper, Audrey L Smith, et al.
International Journal of Molecular Sciences|June 24, 2022
A Novel Triple-Action Inhibitor Targeting B-Cell Receptor Signaling and BRD4 Demonstrates Preclinical Activity in Chronic Lymphocytic LeukemiaAudrey L Smith, Alexandria P Eiken, Sydney A Skupa, et al.
Cancer Research Communications|April 30, 2024
Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical EffectsAlexandria P Eiken, Audrey L Smith, Sydney A Skupa, et al.
Hematological Oncology|August 4, 2021
Impact of initial chemotherapy regimen on outcomes for patients with double-expressor lymphoma: A multi-center analysisChristopher R D'Angelo, Walter Hanel, Yi Chen, et al.
Pageof 3